Published on in Vol 13 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/54042, first published
.
![A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study](https://asset.jmir.pub/assets/269758f971889fdd96d5cfbe3476914f.png 480w,https://asset.jmir.pub/assets/269758f971889fdd96d5cfbe3476914f.png 960w,https://asset.jmir.pub/assets/269758f971889fdd96d5cfbe3476914f.png 1920w,https://asset.jmir.pub/assets/269758f971889fdd96d5cfbe3476914f.png 2500w)
There are currently no tweets available for this article within the specified range.